title: Tissue iron distribution and urinary mineral excretion vary depending on the form of iron (FeSO4 or NaFeEDTA) and the route of administration (oral or subcutaneous) in rats given high doses of iron.
abstract: Sodium iron ethylenediaminetetraacetate (NaFeEDTA) has considerable promise as an iron fortificant in food. However, effects of administering high levels of NaFeEDTA on tissue iron distribution and mineral excretion are not well understood. The objectives of this study were to assess nonheme iron distribution in the body and urinary excretion of Ca, Mg, Cu, Fe, and Zn after daily administration of high levels of iron to rats over 21 days. Iron was either given orally with food or injected subcutaneously, as either FeSO 4 or NaFeEDTA. Selected tissues were collected for nonheme iron analysis. Estimated total body nonheme iron levels were similar in rats fed NaFeEDTA or FeSO 4, but the tissue distribution was different: it was 53% lower in the liver and 86% higher in the kidneys among rats fed NaFeEDTA than among those fed FeSO 4. In contrast, body nonheme iron was 3.2-fold higher in rats injected with FeSO 4 than in rats injected with NaFeEDTA. Administering NaFeEDTA orally elevated urinary Cu, Fe, and Zn excretion compared with FeSO 4 (1.41-, 11.9-, and 13.9-fold higher, respectively). We conclude that iron is dissociated from the EDTA complex prior to or during intestinal absorption. A portion of intact FeEDTA may be absorbed via a paracellular route at high levels of intake but is mostly excreted in the urine. Metal-free EDTA may be absorbed and cause elevated urinary excretion of Fe, Cu, and Zn.
authors: Department of Food Science, Cornell University, Ithaca, New York 14853, USA.
authors: Le
authors: L
authors: Zhu
authors: Dennis D
authors: DD
authors: Miller
mesh_terms: D000818:Animals; D004492:Edetic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005296:Ferrous Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007501:Iron / Q000032:analysis* / Q000493:pharmacokinetics*; D008297:Male; D008903:Minerals / Q000652:urine*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
chemical_list: D005290:Ferric Compounds; D005296:Ferrous Compounds; D008903:Minerals; C020748:ferrous sulfate; D004492:Edetic Acid; D007501:Iron; C019179:Fe(III)-EDTA